Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeADS(ABVX) | 801,224 | 649,179 | -152,045 | $68.02M | $87.55M | 16.07% | +$19.52M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 4,604,878 | 4,496,487 | -108,391 | $62.58M | $54.32M | 9.97% | -$8.26M |
| Cogent Biosciences, Inc.(COGT) | 2,025,041 | 1,217,064 | -807,977 | $29.08M | $43.23M | 7.93% | +$14.15M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 300,610 | 248,070 | -52,540 | $39.62M | $42.17M | 7.74% | +$2.55M |
| Vaxcyte, Inc.(PCVX) | 788,441 | 798,940 | +10,499 | $28.40M | $36.86M | 6.77% | +$8.46M |
| Dyne Therapeutics, Inc.(DYN) | 2,674,469 | 1,788,616 | -885,853 | $33.83M | $34.99M | 6.42% | +$1.15M |
| Pharvaris N V COM | 886,332 | 1,140,033 | +253,701 | $22.11M | $31.64M | 5.81% | +$9.52M |
| Celcuity Inc.(CELC) | 473,828 | 317,095 | -156,733 | $23.41M | $31.63M | 5.80% | +$8.22M |
| Alumis Inc | 0 | 3,135,953 | +3,135,953 | $0 | $30.61M | 5.62% | +$30.61M |
| Disc Medicine, Inc.(IRON) | 340,897 | 298,429 | -42,468 | $22.53M | $23.70M | 4.35% | +$1.17M |
| X4 Pharmaceuticals, Inc.(XFOR) | 0 | 5,800,530 | +5,800,530 | $0 | $23.20M | 4.26% | +$23.20M |
| Monopar Therapeutics Inc.(MNPR) | 155,370 | 325,701 | +170,331 | $12.69M | $21.27M | 3.90% | +$8.58M |
| Invivyd, Inc.(IVVD) | 0 | 7,735,386 | +7,735,386 | $0 | $19.11M | 3.51% | +$19.11M |
| Ocular Therapeutix, Inc.(OCUL) | 1,151,686 | 1,504,880 | +353,194 | $13.46M | $18.27M | 3.35% | +$4.81M |
| Immix Biopharma, Inc.(IMMX) | 0 | 2,999,169 | +2,999,169 | $0 | $15.69M | 2.88% | +$15.69M |
| Oculis Holding AG(OCS) | 0 | 516,761 | +516,761 | $0 | $10.32M | 1.89% | +$10.32M |
| Inhibikase Therapeutics, Inc.(IKT) | 0 | 3,856,799 | +3,856,799 | $0 | $7.91M | 1.45% | +$7.91M |
| Centessa Pharmaceuticals PlcADS | 734,539 | 282,692 | -451,847 | $17.81M | $7.07M | 1.30% | -$10.74M |
| Ovid Therapeutics Inc.(OVID) | 0 | 2,500,000 | +2,500,000 | $0 | $4.08M | 0.75% | +$4.08M |
| Inventiva S.A.ADS(IVA) | 0 | 283,166 | +283,166 | $0 | $1.32M | 0.24% | +$1.32M |
| CG Oncology, Inc.(CGON) | 579,895 | 0 | -579,895 | $23.36M | $0 | — | -$23.36M |
| LENZ Therapeutics, Inc.(LENZ) | 368,176 | 0 | -368,176 | $17.15M | $0 | — | -$17.15M |
| Merus N V | 184,135 | 0 | -184,135 | $17.34M | $0 | — | -$17.34M |
| Newamsterdam Pharma Company ORDINARY SHARES | 153,147 | 0 | -153,147 | $4.36M | $0 | — | -$4.36M |
| Xenon Pharmaceuticals Inc.(XENE) | 503,701 | 0 | -503,701 | $20.22M | $0 | — | -$20.22M |